A Streamlit app for predicting drug-target binding affinity using a trained CNN model. Input SMILES strings and protein sequences for fast and accurate predictions.

Google DeepMind CEO Demis Hassabis envisions AI eradicating all diseases within a decade, potentially revolutionizing drug ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

With tightening budgets and increasing pressure to de-risk R&D, pharma and biotech are shifting their focus toward smarter, more efficient drug design. Companies are investing more in enabling ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

Identifying and characterizing typical drug resistance mechanisms in lung cancer • Developing and validating new drug design strategies for lung cancer therapy • Evaluating the effectiveness of drug ...

Non-Commercial (NC): Only non-commercial uses of the work are permitted. The main purpose of this study was to design and develop a solid self-nanoemulsifying drug delivery system (S-SNEDDS) for the ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Google DeepMind CEO Demis Hassabis envisions AI eradicating all diseases within a decade, potentially revolutionizing drug design. Hassabis, a Nobel laureate for his work on AlphaFold, believes AI ...